Shailendra Giri

Title: Shailendra Giri: Innovator in Ovarian Cancer Treatment

Introduction

Shailendra Giri is a notable inventor based in Rochester, MN (US). He has made significant contributions to the field of cancer treatment, particularly focusing on ovarian cancer. His innovative approach utilizes nanoparticles to inhibit angiogenesis associated with this disease.

Latest Patents

Giri holds a patent for the invention titled "Inhibition of angiogenesis associated with ovarian cancer by nanoparticles of cerium oxide." This invention provides a method for treating ovarian cancer in mammals. The method involves the parenteral administration of an effective amount of cerium oxide nanoparticles, which have a predominance of Ce. This groundbreaking work has the potential to improve treatment outcomes for patients suffering from ovarian cancer.

Career Highlights

Shailendra Giri is affiliated with the University of Central Florida Research Foundation, Inc. His work in this institution has allowed him to explore innovative solutions in cancer research. Giri's dedication to advancing medical science is evident through his research and patent contributions.

Collaborations

Giri has collaborated with notable colleagues such as Sudipta Seal and Ajay Karakoti. These partnerships have enhanced his research efforts and contributed to the development of effective cancer treatment methodologies.

Conclusion

Shailendra Giri's work in the field of ovarian cancer treatment exemplifies the impact of innovative research on healthcare. His patent for using cerium oxide nanoparticles represents a significant advancement in cancer therapy. Giri's contributions continue to inspire future research in this critical area of medicine.